Transcatheter arterial embolization for the treatment of liver metastases in a patient with malignant pheochromocytoma

Endocrine Journal

Volumn 53, Issue 1, 2006, Pages 59-66

  Watanabe, Daisuke ^a   Tanabe, Akiyo ^a   Naruse, Mitsuhide ^b   Tsuiki, Mika ^a   Torii, Nobuyuki ^a   Noshiro, Takao ^c   Takano, Kazue ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^c Noshiro Clinic   (Japan)

Author keywords

Chromogranin A; Malignant pheochromocytoma; Multiple hepatic tumors; Transcatheter arterial embolization (TAE)

Indexed keywords

AMINOTRANSFERASE; BIOLOGICAL MARKER; CARVEDILOL; CATECHOLAMINE; CHROMOGRANIN A; DOXAZOSIN; GELATIN SPONGE; IODINATED POPPYSEED OIL; MITOMYCIN C;

ABDOMINAL PAIN; ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; AMINOTRANSFERASE BLOOD LEVEL; ANOREXIA; ARTICLE; ARTIFICIAL EMBOLISM; BLOOD PRESSURE; CASE REPORT; CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE URINE LEVEL; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; HYPERTENSION; HYPERTENSIVE CRISIS; LABORATORY TEST; LIVER METASTASIS; MALE; MALIGNANT NEOPLASTIC DISEASE; NAUSEA; PHEOCHROMOCYTOMA; PROTEIN BLOOD LEVEL;

ADRENAL GLAND NEOPLASMS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOGRAPHY; ANTIBIOTICS, ANTINEOPLASTIC; BLOOD PRESSURE; CATECHOLAMINES; CHROMOGRANIN A; CHROMOGRANINS; EMBOLIZATION, THERAPEUTIC; GELATIN SPONGE, ABSORBABLE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MITOMYCIN; PHEOCHROMOCYTOMA;

EID: 33645006276     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.53.59     Document Type: Article

References (24)

1. Edstrom Elder E, Hjelm Skog AL, Hoog A, Hamberger B (2003) The management of benign and malignant pheochromocytoma and abdominal paraganglioma. Eur J Surg Oncol 29: 278-283.
2. Averbuch SD, Steakley CS, Young RC, Gelmann EP, Goldstein DS, Stull R, Keiser HR (1988) Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine. Ann Intern Med 109: 267-273.
3. Kopf D, Goretzki PE, Lehnert H (2001) Clinical management of malignant adrenal tumors. J Cancer Res Clin Oncol 127: 143-155.
4. Jaeck D, Paris F, Welsch M, Stephan D, Chenard-Neu MP, Steib A, Bachellier P, Bellocq JP, Imbs JL (1995) Primary hepatic pheochromocytoma: a second case. Surgery 117: 586-590.
5. Mornex R, Badet C, Peyrin L (1992) Malignant pheochromocytoma: a series of 14 cases observed between 1966 and 1990. J Endocrinol Invest 15: 643-649.
6. Yashiro N, Kokubo T, Minami M, Yoshida H, Minowada S (1990) Transarterial embolization of metastatic pheochromocytoma. Jpn J Clin Radiol 35: 983-986 (In Japanese).
7. Takahashi K, Ashizawa N, Minami T, Suzuki S, Sakamoto I, Hayashi K, Tomiyasu S, Sumikawa K, Kitamura K, Eto T, Yano K (1999) Malignant pheochromocytoma with multiple hepatic metastases treated by chemotherapy and transcatheter arterial embolization. Intern Med 38: 349-354.
8. Tanaka S, Ito T, Tomoda J, Higashi T, Yamada G, Tsuji T (1993) Malignant pheochromocytoma with hepatic metastasis diagnosed 20 years after resection of the primary adrenal lesion. Intern Med 32: 789-794.
9. Kido T, Takao T, Sagawa S, Kotoh K (1999) A case of surgical resection of metastatic multiple lung pheochromocytoma with long-term survival. Kyobugeka 52: 458-462 (In Japanese).
10. Rii A, Hara T, Hasuo H, Tomiyasu S, Makita T, Sumikawa K (1999) Monitored anesthesia care for a patient with malignant pheochromocytoma. Masui 48: 634-638 (In Japanese).
11. Komatsu M, Fujii T, Goto T, Ohshima S, Nakane K, Yoneyama K, Ando H, Tanaka J, Hashimoto M (1998) Giant hepatic biloma following transcatheter oily chemoembolization in a patient with hepatic metastases from malignant pheochromocytoma. Intern Med 37: 1034-1038.
12. Machens A, Behrmann C, Dralle H (2000) Chemoembolization of liver metastases from medullary thyroid carcinoma. Ann Intern Med 132: 596-597.
13. Onohara S, Kobayashi H, Uchiyama N, Sonoda T, Oyama T, Shinohara S (1983) A successfully treated case of Malignant pheochromocytoma by arterial embolization using absolute ethanol. Nippon Igaku Hoshasen Zasshi 43: 1-8 (In Japanese).
14. Kumaki N, Kajiwara H, Kameyama K, DeLellis RA, Asa SL, Osamura RY, Takami H (2002) Prediction of malignant behavior of pheochromocytomas and paragangliomas using immunohistochemical techniques. Endocr Pathol 13: 149-156.
15. Okada S (1998) Transcatheter arterial embolization for advanced hepatocellular carcinoma: the controversy continues. Hepatology 27: 1743-1744.
16. Stridsberg M, Eriksson B, Oberg K, Janson ET (2003) A comparison between three commercial kits for chromogranin A measurements. J Endocrinol 177: 337-341.
17. d'Herbomez M, Gouze V, Huglo D, Nocaudie M, Pattou F, Proye C, Wemeau JL, Marchandise X (2001) Chromogranin A assay and (131)I-MIBG scintigraphy for diagnosis and follow-up of pheochromocytoma. J Nucl Med 42: 993-997.
18. Giovanella L, Ceriani L (2002) Serum chromograninalpha immunoradiometric assay in the diagnosis of pheochromocytoma. Int J Biol Markers 17: 130-134.
19. Hsiao RJ, Parmer RJ, Takiyyuddin MA, O'Connor DT (1991) Chromogranin A storage and secretion: sensitivity and specificity for the diagnosis of pheochromocytoma. Medicine (Baltimore) 70: 33-45.
20. Van der Harst E, de Herder WW, de Krijger RR, Bruining HA, Bonjer HJ, Lamberts SW, van den Meiracker AH, Stijnen TH, Boomsma F (2002) The value of plasma markers for the clinical behaviour of phaeochromocytomas. Eur J Endocrinol 147: 85-94.
21. Kimura N, Miura W, Noshiro T, Mizunashi K, Hanew K, Shimizu K, Watanabe T, Shibukawa S, Sohn HE, Abe K, Miura Y, Nagura H (1997) Plasma chromogranin A in pheochromocytoma, primary hyperparathyroidism and pituitary adenoma in comparison with catecholamine, parathyroid hormone and pituitary hormones. Endocr J 44: 319-327.
22. Neumann HP, Berger DP, Sigmund G, Blum U, Schmidt D, Parmer RJ, Volk B, Kirste G (1993) Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease. N Engl J Med 329: 1531-1538.
23. Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhinney SR, Muresan M, Buchta M, Franke G, Klisch J, Bley TA, Hoegerle S, Boedeker CC, Opocher G, Schipper J, Januszewicz A, Eng C; European-American Paraganglioma Study Group (2004) Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 292: 943-951.
24. Bertherat J, Gimenez-Roqueplo AP (2005) New insights in the genetics of adrenocortical tumors, pheochromocytomas and paragangliomas. Horm Metab Res 37: 384-390.